MEDICAL DEVICE

• US 20090210249A1
• Filed: 02/13/2009
• Published: 08/20/2009
• Est. Priority Date: 02/16/2008
• Status: Abandoned Application

• Current Assignee: Roche Diabetes Care Inc. (Roche Holding AG)
• Original Assignee: Roche Diabetes Care Inc. (Roche Holding AG)
• Inventors: Rasch-Menges, Juergen, Jansen, Paul
• Application Number:
  US12/370,853
• Publication Number:
  US 20090210249A1
• Time in Patent Office: Days
• US Class Current: 705/2
• CPC Class Codes: G16H 10/40 for data related to laboratory analysis, e.g. patient specimen analysis
• CPC Class Codes: G16H 10/65 stored on portable record carriers, e.g. on smartcards, RFID tags or CD
• CPC Class Codes: G16H 40/63 for local operation

Abstract

A medical device is provided, comprising a data management unit for providing patient data regarding a patient'"'"'s health and/or treatment status, a display for displaying the patient data provided by the data management unit, and an actuator configured to cause one or both of activation and deactivation of the device. The patient data is displayed on the display in response to the initiation of activation and/or deactivation of the device.

Claims

1. A medical device comprising a data management unit for providing patient data regarding at least one of a patient'"'"'s health and treatment status, a display for displaying the patient data provided by the data management unit, and an activator configured to initiate one or both of activation and deactivation of the device, wherein the device is configured to display the patient data on the display upon one or both of the activation or deactivation of the device.

2. The device according to claim 1, wherein the activator comprises operating controls on the device, and wherein the deactivation can be interrupted via the operating controls while the patient data is displayed.

3. The device according to claim 1, wherein the patient data is displayed together with a progress indicator that indicates progression of the deactivation.

4. The device according to claim 1, wherein the deactivation comprises an initial stage, during which continued actuation of operating controls is necessary to prevent abortion of the deactivation process, and a subsequent secondary stage, the patient data being displayed during both said stages.

5. The device according to claim 1, wherein the data management unit provides the patient data as an analysis result based on a plurality of one or both of measurement data and medication data.

6. The device according to claim 1, wherein the patient data comprises a comparison of an actual frequency of measurements and a desired value for frequency of measurements.

7. The device according to claim 1, wherein the patient data comprises information relating to a patient'"'"'s metabolic status.

8. The device according to claim 1, wherein the patient data comprises an analysis result based on a plurality of data relating to one or both of measurements and medication, said data being determined over the course of a previous period of between at least about 24 hours and about five days.

9. The device according to claim 1, wherein the data management unit comprises an integral part of the device.

10. The device according to claim 1, wherein the data management unit is operatively connected to a measuring unit configured for determining an analyte concentration of a sample of a body fluid.

11. The device according to claim 10, wherein the data management unit is connected to the measuring unit via a wireless or wired data communication.

12. The device according to claim 1, wherein the device comprises one of a blood glucose meter, a glucose monitoring device, a medical data management device, and an infusion device.